SpectronRx to open new facility on SCK CEN premises

By AuntMinnieEurope.com staff writers

May 26, 2023 -- SpectronRx has revealed that it plans to open a new facility at the Belgian Nuclear Research Center (SCK CEN) in Mol, Belgium.

The two organizations have signed a Memorandum of Understanding that states that SpectronRx will provide equipment to the facility and SCK CEN will supply resources for the production of radiopharmaceuticals -- particularly the therapeutic Actinium-225 -- and staff to handle radiolabeling.

Actinium-225 is intended to treat prostate, lung, colon, breast, pancreas, blood, and kidney cancers, as well as glioblastoma, a very invasive brain cancer, SpectronRx said.

Copyright © 2023 AuntMinnieEurope.com

To read this and get access to all of the exclusive content on AuntMinnieEurope.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnieEurope.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking